Company / Book Value per Share
Zentalis Pharmaceuticals, Inc. Book Value per Share History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Book Value per Share
$3.033
FY2025
5-year range
$3.033 / $4.765
FY2024-FY2025
Trend
-36.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$3.033 in FY2025.
Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, book value per share decreased 36.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -1.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.033 | -36.3% |
| FY2024 | $4.765 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026